Variables related to bronchopulmonary dysplasia severity: a Six-Year retrospective study

Abstract Objectives This was a retrospective observational study conducted in a tertiary neonatal intensive care unit, in order to investigate factors which influenced the severity of bronchopulmonary dysplasia under NICHD new classification. Methods Six years of clinical data with different grades of bronchopulmonary dysplasia patients were collected and analyzed, bivariate ordinal logistic regression model and multivariable ordinal logistic regression model were used with sensitivity analyses. Results We identified seven variables were associated with the severity of BPD via a bivariate ordinal logistic regression model, including the level of referral hospital (OR 0.273;95% CI 0.117, 0.636), method of caffeine administration (OR 00.418;95% CI 0.177, 0.991), more than two occurrences of reintubation (OR 4.925;95% CI 1.878, 12.915), CPAP reapplication (OR 2.255;95% CI 1.059, 4.802), presence of positive sputum cultures (OR 2.574;95% CI 1.200, 5.519), the cumulative duration of invasive ventilation (OR 1.047;95% CI 1.017, 1.078), and postmenstrual age at the discontinuation of oxygen supplementation (OR 1.190;95% CI 1.027, 1.38). These seven variables were further analyzed via all multivariable ordinal logistic regression models, and we found that tertiary hospital birth and early administration of caffeine could reduce the severity of BPD by approximately 70% (OR 0.263;95% CI 0.090, 0.770) and 60% (OR 0.371;95% CI 0.138, 0.995), respectively. In contrast, multiple reintubations were related to higher BPD severity with an OR of 3.358 (95% CI 1.002, 11.252). Conclusion Improving perinatal care in level II hospitals, standardized caffeine administration, and optimized extubation strategy could potentially decrease the severity of BPD.

[1]  Bo Wang,et al.  Prediction Models for Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review , 2022, Frontiers in Pediatrics.

[2]  Shoo K. Lee,et al.  Variations in length of stay among survived very preterm infants admitted to Chinese neonatal intensive care units , 2022, World Journal of Pediatrics.

[3]  A. Earnest,et al.  Respiratory management and bronchopulmonary dysplasia in extremely preterm infants: a comparison of practice between centres in Oxford and Melbourne , 2022, Journal of Perinatology.

[4]  Tingwen Shen,et al.  Development and verification of a risk prediction model for bronchopulmonary dysplasia in very low birth weight infants , 2021, Translational pediatrics.

[5]  Yang Wang,et al.  A Prediction Model of Extubation Failure Risk in Preterm Infants , 2021, Frontiers in Pediatrics.

[6]  R. Sindelar,et al.  Early extubation is associated with shorter duration of mechanical ventilation and lower incidence of bronchopulmonary dysplasia. , 2021, Early human development.

[7]  A. Concheiro-Guisán,et al.  Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network , 2021, European Journal of Pediatrics.

[8]  Mengyuan Lei,et al.  Development and Validation of a Nomogram for Predicting Bronchopulmonary Dysplasia in Very-Low-Birth-Weight Infants , 2021, Frontiers in Pediatrics.

[9]  Í. Barreto,et al.  Factors associated with extubation failure in very low birth weight infants: a cohort study in the northeast Brazil , 2020, Journal of perinatal medicine.

[10]  E. Jensen What is bronchopulmonary dysplasia and does caffeine prevent it? , 2020, Seminars in fetal & neonatal medicine.

[11]  N. Bamat,et al.  The Clinical Evaluation of Severe Bronchopulmonary Dysplasia. , 2020, NeoReviews.

[12]  L. Du,et al.  [A comparison of the clinical diagnosis and outcome in preterm infants with bronchopulmonary dysplasia under two different diagnostic criteria]. , 2020, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[13]  R. Ayyagari,et al.  Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants , 2019, Front. Pediatr..

[14]  P. Davis,et al.  Bronchopulmonary dysplasia , 2019, Nature Reviews Disease Primers.

[15]  G. Marshall,et al.  Bronchopulmonary dysplasia: risk prediction models for very-low- birth-weight infants , 2019, Journal of Perinatology.

[16]  Lara J. Kanbar,et al.  The Impact of Time Interval between Extubation and Reintubation on Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants , 2019, The Journal of pediatrics.

[17]  A. Synnes,et al.  Early Caffeine Administration and Neurodevelopmental Outcomes in Preterm Infants , 2018, Pediatrics.

[18]  T. Raju,et al.  Bronchopulmonary Dysplasia: Executive Summary of a Workshop , 2018, The Journal of pediatrics.

[19]  M. Miedema,et al.  High versus standard dose caffeine for apnoea: a systematic review , 2018, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[20]  W. Göpel,et al.  Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development , 2017, The Journal of pediatrics.

[21]  Sarah E Lillie,et al.  Markers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed Extubation , 2017, The Journal of pediatrics.

[22]  P. Tsao,et al.  Risk Factors for Extubation Failure in Extremely Low Birth Weight Infants. , 2017, Pediatrics and neonatology.

[23]  E. Jensen,et al.  Effects of Multiple Ventilation Courses and Duration of Mechanical Ventilation on Respiratory Outcomes in Extremely Low-Birth-Weight Infants. , 2015, JAMA pediatrics.

[24]  M. Walsh,et al.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. , 2015, JAMA.

[25]  V. Bhandari,et al.  Impact of Early Extubation and Reintubation on the Incidence of Bronchopulmonary Dysplasia in Neonates , 2014, American Journal of Perinatology.

[26]  Z. Aghai,et al.  Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[27]  M. Laughon,et al.  Medication Use in the Neonatal Intensive Care Unit , 2013, American Journal of Perinatology.

[28]  P. Davis,et al.  Definitions of extubation success in very premature infants: a systematic review , 2013, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[29]  G. Badger,et al.  Mortality and Neonatal Morbidity Among Infants 501 to 1500 Grams From 2000 to 2009 , 2012, Pediatrics.

[30]  L. Doyle,et al.  Caffeine therapy for apnea of prematurity. , 2006, The New England journal of medicine.

[31]  M. Walsh,et al.  Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia , 2005, Pediatrics.

[32]  Jeffrey A. Golden,et al.  Dysplasia , 2003, Neurology.

[33]  W. Northway,et al.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.

[34]  L. Nelin,et al.  Early extubation attempts reduce length of stay in extremely preterm infants even if re-intubation is necessary. , 2015, Journal of neonatal-perinatal medicine.

[35]  L. Monte,et al.  [Bronchopulmonary dysplasia]. , 2005, Jornal de pediatria.

[36]  P. Davis,et al.  Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. , 2001, The Cochrane database of systematic reviews.